Cognetix, Inc.

• Position: Salt Lake City - Receives patent for Contulakin-G - Brief Article

Salt Lake City - COGNETIX, INC. has received United States patent number 6,489,298 from the U.S. Patent and Trademark Office for the use of Contulakin-G (CGX1160) for the treatment of acute and chronic pain. This is the fourth patent in the company's...